GMP: FDA Safety Communication: New boxed warning for thrombosis related to human immune globulin products.

The analysis of recent data by the U.S. Food and Drug Administration (FDA) has strengthened the association between the use of intravenous, subcutaneous and intramuscular human immune globulin products and the risk of thrombosis. And the FDA suggested that additional caution regarding the use of these products is warranted.

kapitał ludzki

fundusz społeczny

Narodowe Centrum Badań i Rozwoju

innowacyjna gospodarka

rozwój regionalny